FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
Contenido no disponible. Consulta la fuente original.
FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.